Therapeutic options for postmenopausal female sexual dysfunction

被引:51
|
作者
Al-Azzawi, F. [1 ]
Bitzer, J. [2 ]
Brandenburg, U. [3 ]
Castelo-Branco, C. [4 ]
Graziottin, A. [5 ]
Kenemans, P. [6 ]
Lachowsky, M. [7 ]
Mimoun, S. [8 ]
Nappi, R. E. [9 ]
Palacios, S. [11 ]
Schwenkhagen, A. [10 ]
Studd, J. [12 ]
Wylie, K. [13 ]
Zahradnik, H. -P. [14 ]
机构
[1] Univ Hosp Leicester, Gynaecol Res Unit, Leicester, Leics, England
[2] Univ Basel Hosp, Dept Obstet & Gynecol, CH-4031 Basel, Switzerland
[3] Klin Psychiat & Psychotherapie, Aachen, Germany
[4] Univ Barcelona, Fac Med, Inst Clin Gynecol Obstet & Neonatol, Hosp Clin,IDIBAPS, Barcelona 7, Spain
[5] H San Raffaele Resnati, Ctr Gynecol & Med Sexol, Milan, Italy
[6] Free Univ Amsterdam, Med Ctr, Dept Obstet & Gynecol, Amsterdam, Netherlands
[7] Hop Xavier Bichat, Paris, France
[8] Robert Debre Hosp, Dept Obstet & Gynecol, Unit Psychosomat Gynecol, Paris, France
[9] Univ Pavia, IRCCS Maugeri Fdn, Res Ctr Reprod Med, I-27100 Pavia, Italy
[10] Ctr Gynecol Endocrinol & Reprod Med, Hamburg, Germany
[11] Inst Palacios Salud & Med Mujer, Madrid, Spain
[12] London PMS & Menopause Ctr, London, England
[13] Porterbrook Clin, Sheffield, S Yorkshire, England
[14] Univ Frauenklin, Klin Endokrinol & Reprod Med, Freiburg, Germany
关键词
FEMALE SEXUAL DYSFUNCTION; MENOPAUSE; ESTROGEN; TESTOSTERONE; DEFICIENCY; PSYCHOSOCIAL; SURGICALLY MENOPAUSAL WOMEN; QUALITY-OF-LIFE; DESIRE DISORDER; AROUSAL DISORDER; DOUBLE-BLIND; TESTOSTERONE PATCH; DEHYDROEPIANDROSTERONE REPLACEMENT; ESTROGEN THERAPY; UNITED-STATES; PREVALENCE;
D O I
10.3109/13697130903437615
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective To review the pharmacological and non-pharmacological therapies available for postmenopausal FSD, focusing on practical recommendations for managing postmenopausal women with sexual complaints, through a literature review of the most relevant publications in this field. Psychosocial therapy This type of therapy (basic counselling, physiotherapy and psychosexual intervention) is considered an adaptable step-by-step approach for diagnostic and therapeutic strategies, normally combined with biomedical interventions to provide optimal outcomes. Pharmacological therapy For postmenopausal FSD, many interventional options are now available, including hormonal therapies such as estrogens, testosterone, combined estrogen/testosterone, tibolone and dehydroepiandrosterone. Conclusions Menopause and its transition represent significant risk factors for the development of sexual dysfunction. FSD impacts greatly on a patient's quality of life. Consequently, it is receiving more attention thanks to the development of effective treatments. Non-pharmacological approaches should be used first, focusing on lifestyle and psychosexual therapy. If required, proven effective hormonal and non-hormonal therapeutic options are available.
引用
收藏
页码:103 / 120
页数:18
相关论文
共 50 条
  • [1] Female sexual dysfunction in postmenopausal women
    Castelo-Branco, Camil
    Cancelo, Maria J.
    Chedraui, Peter
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2007, 17 (06) : 639 - 647
  • [2] Pharmacologic therapeutic options for sexual dysfunction
    Burton, Claire S.
    Mishra, Kavita
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2022, 34 (06) : 402 - 408
  • [3] Female sexual dysfunction
    Jha, Swati
    Thakar, Ranee
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2010, 153 (02) : 117 - 123
  • [4] Managing female sexual dysfunction
    Buster, John E.
    FERTILITY AND STERILITY, 2013, 100 (04) : 905 - 915
  • [5] Female Sexual Dysfunction
    Lindau, Stacy Tessler
    Abramsohn, Emily
    OBSTETRICS AND GYNECOLOGY, 2019, 134 (01): : E1 - E18
  • [6] An update on the pharmacological management of female sexual dysfunction
    Fooladi, Ensieh
    Davis, Susan R.
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (15) : 2131 - 2142
  • [7] Status of female sexual dysfunction among postmenopausal women in Bangladesh
    Amin, Mohammad Ashraful
    Mozid, Nusrat-E
    Ahmed, Sanjana Binte
    Sharmin, Shakila
    Monju, Imran Hossain
    Jhumur, Shirin Shahadat
    Sarker, Wharesha
    Dalal, Koustuv
    Hawlader, Mohammad Delwer Hossain
    BMC WOMENS HEALTH, 2022, 22 (01)
  • [8] Testosterone for Treating Female Sexual Dysfunction
    Simon, James A.
    Ohleth, Kathleen
    CLINICAL OBSTETRICS AND GYNECOLOGY, 2025, 68 (01): : 60 - 67
  • [9] Female Sexual Dysfunction: Is It a Treatable Disease?
    Houman, Justin
    Feng, Tom
    Eilber, Karyn S.
    Anger, Jennifer T.
    CURRENT UROLOGY REPORTS, 2016, 17 (04) : 1 - 6
  • [10] Female Sexual Dysfunction
    Clayton, Anita H.
    Hamilton, David V.
    OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 2009, 36 (04) : 861 - +